№ files_lp_4_process_3_073057
Regulatory disclosure filing reporting transactions in common stock and performance-based equity awards by the Chief Financial Officer of Indivior Pharmaceuticals, Inc. under U.S. securities law reporting requirements.
Country: United States
Regulatory Authority: U.S. Securities and Exchange Commission
Form Type: SEC Form 4
Legal Basis: Section 16(a) of the Securities Exchange Act of 1934; Section 30(h) of the Investment Company Act of 1940
Issuer: Indivior Pharmaceuticals, Inc.
Ticker Symbol: INDV
Reporting Person: Ryan Preblick
Position of Reporting Person: Chief Financial Officer
Address of Reporting Person: 10710 Midlothian Turnpike, Suite 125, North Chesterfield, VA 23235
Date of Earliest Transaction: February 9, 2026
Filing Date: February 12, 2026
Transaction Type: Acquisition of non-derivative securities and derivative securities
Security Type: Common Stock; Performance Stock Units; Restricted Stock Units
Amount of Common Stock Acquired: 37,358 shares
Price per Share: $0
Total Beneficially Owned Following Transaction: 317,940 shares
Derivative Security: Performance Stock Units
Number of Derivative Securities Acquired: 113,510 units
Underlying Security: Common Stock
Vesting Schedule: Three equal annual installments beginning February 10, 2027
Performance Certification Date: February 9, 2026
Vesting Date of Conditional Award: March 3, 2026
Holding Period After Vesting: Two years
Signature Authority: Alice Givens (Power of Attorney)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.